Diabetes

Dipeptidyl peptidase-4 inhibitor shown to help even those patients with poorly controlled diabetes

Q. With all the controversy over the benefits vs costs of home blood glucose monitoring in patients with type 2 diabetes who are not receiving insulin, what are you recommending to your patients?

Move brings Canada closer to world standards

Researcher believes relationship to be causal; but benefit is lower mortality

Indicated for use in combination with metformin and/or a sulfonylurea to improve glycemic control in adults with type 2 diabetes.

But those with diabetes are not getting the best care, as evidenced by the high rate of hospitalizations

Researcher urges caution in interpreting results

Initiative assists people with diabetes who have difficulty covering the costs of blood glucose monitoring supplies.